Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Topical sensitizers have mixed success in treating alopecia areata.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Light scatters differently from elliptical hair fibers than from circular ones, and a new model better predicts this behavior, especially for shiny highlights.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Splitting single-hair grafts seems to improve perceived hair fullness without affecting growth, intact grafts grow slightly better, and the Mantis microscope is clear but slower without reducing damage to grafts.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.

Topical minoxidil showed limited effectiveness for hair regrowth in alopecia areata.

Dried blood spots can be as stable as frozen liquid samples for storing certain metabolites.

The combination of encorafenib and binimetinib caused few skin issues.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

The technique helps measure how hair styling ingredients affect hair's stiffness and flexibility.

The document does not provide information about hair loss treatment.

Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

The research confirmed that certain methods are reliable for standardizing Eclipta alba and ensuring its safety and quality in herbal products.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

The dfRootChip revealed how Arabidopsis roots adapt and grow in uneven conditions.

UVF-dermoscopy is a useful tool for accurately diagnosing types of alopecia, especially in people with lighter skin.